Clinical trial · Interventional
Using Artificial Intelligence-based ChatBot to Improve Women's Participation to Cervical Cancer Screening Programme
Artificial Intelligence-assisted Decision-making to Improve Women's Participation to Cervical Cancer Screening in Occitanie Region-France
NCT05286034CI-TRIAL-00106535AppDate-YourecruitingN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This project looks to improve the return rate of HPV self-sampling (HPVss) as well as the management of women HPVss positive.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cervical Cancer | Malignant Cervical Neoplasm | CURATED_EXACT | 0.92 |
| Cervical Cancer Screening | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Decision aid tailored to women with lower educational attainment,accessible via artificial intelligence-based Chatbot platforms | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Intervention group
- description
- Women randomized to this group will be sent screening reminder letters to perform HPV self-sampling test, with access to a decision aid tool tailored to those with low education levels. This tool will be available via Chatbot platforms.
- interventionNames
- Behavioral: Decision aid tailored to women with lower educational attainment,accessible via artificial intelligence-based Chatbot platforms
- type
- NO_INTERVENTION
- label
- Control group
- description
- Women randomized to this group will be sent screening reminder letters to perform HPV self-sampling test (Standard care)
Primary outcomes (3)
- measure
- HPV self-sampling "return" rate
- timeFrame
- 1 year after postal mail
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 30 Years
- Maximum age
- 65 Years
Show eligibility criteria text
Inclusion criteria: eligible women will be: * aged 30-65 * did not perform a pap smear in the last 4 years * are living in deprived clusters in the Occitanie region. * did not answer to a first "invitation" letter to perform a clinician-collected HPV testing Exclusion criteria: ineligible women will be those: * outside the target age group * had a Pap smear in the past 3 years * had hysterectomy including cervix * are pregnant * already scheduled a screening appointment or had just attended a HPV screening * had a cervical abnormality that was under exploration and/or treatment. * participated to the study pilot
References
Publications (1)
- BACKGROUNDSelmouni F, Guy M, Muwonge R, Nassiri A, Lucas E, Basu P, Sauvaget C. Effectiveness of Artificial Intelligence-Assisted Decision-making to Improve Vulnerable Women's Participation in Cervical Cancer Screening in France: Protocol for a Cluster Randomized Controlled Trial (AppDate-You). JMIR Res Protoc. 2022 Aug 2;11(8):e39288. doi: 10.2196/39288. PMID 35771872